Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
4.700
-0.080 (-1.67%)
May 12, 2025, 4:00 PM - Market closed
Company Description
Basel Medical Group Ltd provides healthcare services in Singapore.
The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as other complex neurosurgical procedures.
Its services also include consultation, medical diagnosis, and medical and surgical treatments for orthopedic, trauma, sports medicine, and neurological conditions, as well as physiotherapy services.
The company was incorporated in 2023 and is headquartered in Singapore.
Basel Medical Group Ltd
Country | Singapore |
Founded | 2001 |
IPO Date | Feb 25, 2025 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 32 |
CEO | Yen Feng Chhoa |
Contact Details
Address: 6 Napier Road, Unit No. 02-10/11 Singapore, 258499 Singapore | |
Phone | 65 6291 9188 |
Website | baselmedical.com |
Stock Details
Ticker Symbol | BMGL |
Exchange | NASDAQ |
Fiscal Year | July - June |
Reporting Currency | SGD |
IPO Price | $4.00 |
CIK Code | 0002004489 |
SIC Code | 8011 |
Key Executives
Name | Position |
---|---|
Dr. Yen Feng Chhoa M.D. | Group Chief Health Officer and Interim Chief Executive Officer |
Keng Leong Fung | Executive Chairman of the Board |
Jianing Lu | Group Chief Financial Officer and Director |
Wee Keong Teo | Group Chief Partnership Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 30, 2025 | 6-K | Report of foreign issuer |
Apr 30, 2025 | SCHEDULE 13G | Filing |
Apr 21, 2025 | 6-K | Report of foreign issuer |
Apr 11, 2025 | 6-K | Report of foreign issuer |
Apr 4, 2025 | 6-K | Report of foreign issuer |
Mar 25, 2025 | 6-K | Report of foreign issuer |
Mar 19, 2025 | 6-K | Report of foreign issuer |
Mar 6, 2025 | 6-K | Report of foreign issuer |
Mar 3, 2025 | 6-K | Report of foreign issuer |
Feb 28, 2025 | 6-K | Report of foreign issuer |